Astena Holdings Co., Ltd. (8095.T)
JPY 434.0
(-0.46%)
JPY 434.0
(-0.46%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 4.17 Billion JPY | 22.16% |
| 2022 | 3.9 Billion JPY | -29.91% |
| 2021 | 5.21 Billion JPY | 27.99% |
| 2020 | 4.27 Billion JPY | 8.07% |
| 2019 | 3.17 Billion JPY | 12.85% |
| 2018 | 2.77 Billion JPY | -47.66% |
| 2017 | 2.43 Billion JPY | -9.21% |
| 2016 | 1.52 Billion JPY | 10.35% |
| 2015 | 1.69 Billion JPY | -6.9% |
| 2014 | 1.88 Billion JPY | 1.79% |
| 2013 | 2.01 Billion JPY | -1.85% |
| 2012 | 2.18 Billion JPY | 4.49% |
| 2011 | 2.76 Billion JPY | 51.03% |
| 2010 | 1.32 Billion JPY | 45.57% |
| 2009 | 635.79 Million JPY | 4.24% |
| 2008 | 467.26 Million JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 1.52 Billion JPY | 44.89% |
| 2024 Q3 | 1 Billion JPY | -28.31% |
| 2024 Q1 | 1.01 Billion JPY | -48.04% |
| 2023 Q3 | 522.23 Million JPY | 44.54% |
| 2023 Q2 | 361.3 Million JPY | 847.76% |
| 2023 FY | - JPY | 22.16% |
| 2023 Q4 | 1.33 Billion JPY | 156.18% |
| 2023 Q1 | -48.31 Million JPY | -114.8% |
| 2022 FY | - JPY | -29.91% |
| 2022 Q1 | 675.86 Million JPY | 85.75% |
| 2022 Q3 | -305.14 Million JPY | -263.98% |
| 2022 Q2 | 186.08 Million JPY | -72.47% |
| 2022 Q4 | 326.45 Million JPY | 206.98% |
| 2021 FY | - JPY | 27.99% |
| 2021 Q2 | 882.22 Million JPY | 22.5% |
| 2021 Q1 | 720.18 Million JPY | 55.67% |
| 2021 Q3 | 485.24 Million JPY | -45.0% |
| 2021 Q4 | 363.84 Million JPY | -25.02% |
| 2020 FY | - JPY | 8.07% |
| 2020 Q3 | 598.4 Million JPY | -2.62% |
| 2020 Q1 | 299.99 Million JPY | -32.26% |
| 2020 Q2 | 614.47 Million JPY | 104.83% |
| 2020 Q4 | 462.63 Million JPY | -22.69% |
| 2019 FY | - JPY | 12.85% |
| 2019 Q2 | 794.74 Million JPY | 44.27% |
| 2019 Q1 | 550.86 Million JPY | 19.49% |
| 2019 Q3 | 488.96 Million JPY | -38.48% |
| 2019 Q4 | 442.83 Million JPY | -9.43% |
| 2018 Q4 | 461.02 Million JPY | -23.72% |
| 2018 FY | - JPY | -47.66% |
| 2018 Q2 | 822.09 Million JPY | 722.5% |
| 2018 Q1 | 99.95 Million JPY | -96.82% |
| 2018 Q3 | 604.36 Million JPY | -26.48% |
| 2017 Q4 | 3.14 Billion JPY | 645.5% |
| 2017 FY | - JPY | -9.21% |
| 2017 Q3 | 421.26 Million JPY | -16.98% |
| 2017 Q2 | 507.42 Million JPY | 22.8% |
| 2017 Q1 | 413.19 Million JPY | -89.98% |
| 2016 Q1 | 167 Million JPY | -95.44% |
| 2016 FY | - JPY | 10.35% |
| 2016 Q4 | 4.12 Billion JPY | 1097.11% |
| 2016 Q3 | 344.59 Million JPY | 79.86% |
| 2016 Q2 | 191.59 Million JPY | 14.72% |
| 2015 Q1 | 123.39 Million JPY | -96.95% |
| 2015 Q2 | 327.95 Million JPY | 165.79% |
| 2015 Q3 | 174.04 Million JPY | -46.93% |
| 2015 FY | - JPY | -6.9% |
| 2015 Q4 | 3.65 Billion JPY | 2002.73% |
| 2014 Q2 | 421.8 Million JPY | 132.47% |
| 2014 Q1 | 181.44 Million JPY | -95.23% |
| 2014 FY | - JPY | 1.79% |
| 2014 Q4 | 4.04 Billion JPY | 3823.49% |
| 2014 Q3 | 103.12 Million JPY | -75.55% |
| 2013 Q3 | 352.35 Million JPY | -27.21% |
| 2013 Q4 | 3.8 Billion JPY | 980.55% |
| 2013 FY | - JPY | -1.85% |
| 2013 Q1 | 97.05 Million JPY | -97.53% |
| 2013 Q2 | 484.08 Million JPY | 398.78% |
| 2012 Q3 | 233.92 Million JPY | -47.31% |
| 2012 Q2 | 443.94 Million JPY | 65.26% |
| 2012 Q4 | 3.93 Billion JPY | 1582.92% |
| 2012 FY | - JPY | 4.49% |
| 2012 Q1 | 268.64 Million JPY | -92.76% |
| 2011 Q2 | 532.31 Million JPY | -13.32% |
| 2011 FY | - JPY | 51.03% |
| 2011 Q1 | 614.13 Million JPY | -77.16% |
| 2011 Q3 | 528.03 Million JPY | -0.8% |
| 2011 Q4 | 3.7 Billion JPY | 602.25% |
| 2010 Q1 | 146.61 Million JPY | -93.38% |
| 2010 Q3 | 318.91 Million JPY | -22.23% |
| 2010 Q2 | 410.05 Million JPY | 179.68% |
| 2010 FY | - JPY | 45.57% |
| 2010 Q4 | 2.68 Billion JPY | 742.99% |
| 2009 Q3 | 351.55 Million JPY | 1172.6% |
| 2009 Q1 | -83.55 Million JPY | 0.0% |
| 2009 FY | - JPY | 4.24% |
| 2009 Q2 | -32.77 Million JPY | 60.78% |
| 2009 Q4 | 2.21 Billion JPY | 529.52% |
| 2008 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| HEARTSEED INC | -1.44 Billion JPY | 388.084% |
| Cawachi Limited | 11.85 Billion JPY | 64.797% |
| Pharmarise Holdings Corporation | 2.08 Billion JPY | -100.011% |
| Qol Holdings Co., Ltd. | 14.21 Billion JPY | 70.641% |
| MatsukiyoCocokara & Co. | 98.01 Billion JPY | 95.743% |
| Welcia Holdings Co., Ltd. | 67.62 Billion JPY | 93.83% |
| Create SD Holdings Co., Ltd. | 24.34 Billion JPY | 82.864% |
| NIHON CHOUZAI Co.,Ltd. | 14.65 Billion JPY | 71.53% |
| COSMOS Pharmaceutical Corporation | 51.42 Billion JPY | 91.887% |
| Tsuruha Holdings Inc. | 67.2 Billion JPY | 93.792% |
| Ohki Healthcare Holdings Co.,Ltd. | 3.81 Billion JPY | -9.335% |
| Satudora Holdings Co.,Ltd. | 2.71 Billion JPY | -53.843% |
| Kusuri No Aoki Holdings Co., Ltd. | 30.64 Billion JPY | 86.384% |
| Medical System Network Co., Ltd. | 6.99 Billion JPY | 40.363% |
| Shinnihonseiyaku Co., Ltd. | 4.18 Billion JPY | 0.377% |
| Sugi Holdings Co.,Ltd. | 50.74 Billion JPY | 91.778% |
| YAKUODO HOLDINGS Co., Ltd. | 8.16 Billion JPY | 48.889% |
| Genky DrugStores Co., Ltd. | 14.47 Billion JPY | 71.174% |
| Ain Holdings Inc. | 31.22 Billion JPY | 86.637% |
| Sundrug Co.,Ltd. | 56.23 Billion JPY | 92.581% |